Document Detail


Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth.
MedLine Citation:
PMID:  9619850     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies indicated that exogenous dopamine and its agonists directly regulated mitogen-induced immune cell proliferation. In this study, we further investigated role of endogenous dopamine in immune cell growth. Haloperidol, a general antagonist for dopamine receptors, could reduce the cell growth rate of T cell hybridoma (10I) and rat nervous pheochromocytoma cells (PC12). Tyrosine hydroxylase (TH) catalyzes the initial rate-limiting step of catecholamine biosynthesis in the nervous system. Flow cytometric analysis indicated the expression of TH in various immune cells. The presence of TH in PC12 cells was used as a control. Temporal studies indicated that the expression of TH increased during 10I cell growth. Both alpha-methyl-p-tyrosine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduced TH expression and cell growth in a dose-dependent manner. These results suggest that immune T cells express TH which is correlated to cell growth, and that dopamine released from these cells may bind to the receptors to act in an autocrine or paracrine way.
Authors:
C W Tsao; Y S Lin; J T Cheng
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Life sciences     Volume:  62     ISSN:  0024-3205     ISO Abbreviation:  Life Sci.     Publication Date:  1998  
Date Detail:
Created Date:  1998-06-18     Completed Date:  1998-06-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375521     Medline TA:  Life Sci     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  PL 335-44     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, National Cheng Kung University Medical College, Tainan, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
Animals
Cell Division / drug effects*
Dopamine Agents / pharmacology
Dopamine Antagonists / pharmacology*
Enzyme Inhibitors / pharmacology
Flow Cytometry
Gene Expression* / drug effects
Haloperidol / pharmacology*
Humans
Hybridomas
Mice
PC12 Cells / cytology
Rats
T-Lymphocytes / cytology*
Tumor Cells, Cultured
Tyrosine 3-Monooxygenase / antagonists & inhibitors,  genetics*
alpha-Methyltyrosine / pharmacology
Chemical
Reg. No./Substance:
0/Dopamine Agents; 0/Dopamine Antagonists; 0/Enzyme Inhibitors; 28289-54-5/1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 52-86-8/Haloperidol; 658-48-0/alpha-Methyltyrosine; EC 1.14.16.2/Tyrosine 3-Monooxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cross tolerance to environmental stress and endotoxin.
Next Document:  Induction of hepatic poly(ADP-ribose) polymerase by peroxisome proliferators, non-genotoxic hepatoca...